Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance
T. R. Browne, G. Szabó, J. E. Evans, Barbara Evans, David J. Greenblatt, Mohamad A. Mikati
Abstract
T. R. Browne, G. Szabó, J. E. Evans, Barbara Evans, David J. Greenblatt, Mohamad A. Mikati
Abstract
Addition of carbamazepine to phenytoin monotherapy resulted in the following significant (p less than 0.05) changes: (1) increased mean phenytoin serum concentration; (2) decreased phenytoin clearance, due to decreased production of phenytoin dihydrodiol and p-hydroxyphenyl-phenylhydantoin; (3) increased phenytoin elimination half-life; and (4) increased drug-related toxicity. Close monitoring is required after addition of carbamazepine to phenytoin.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Addition of carbamazepine to phenytoin monotherapy resulted in the following significant (p less than 0.05) changes: (1) increased mean phenytoin serum concentration; (2) decreased phenytoin clearance, due to decreased production of phenytoin dihydrodiol and p-hydroxyphenyl-phenylhydantoin; (3) increased phenytoin elimination half-life; and (4) increased drug-related toxicity. Close monitoring is required after addition of carbamazepine to phenytoin.
Key concepts: Phenytoin, Carbamazepine, Anticonvulsant, Pharmacology, Medicine, Drug, Epilepsy, Anesthesia